Enterprise Imaging Viewer Receives Clearance for Additional Apps
|
By MedImaging International staff writers Posted on 15 Aug 2017 |

Image: Advanced clinical applications in use on the XERO universal viewer (Photo courtesy of Agfa Healthcare).
A major medical hardware and software provider has received US FDA 510(k) clearance for additional functionalities on its enterprise imaging zero-footprint viewer.
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
The viewer merges patient images and data from different departments and various sources in a hospital. Clinicians inside and outside a hospital, who satisfy the security policies and have the appropriate access rights, can now use the viewer to access the Digital Imaging and Communications in Medicine (DICOM) and non-DICOM imaging data in a single consolidated view.
The US FDA approval includes Xtend 3D processing and advanced clinical applications functionality on the Agfa Healthcare (Mortsel, Belgium) XERO Viewer. The functionality is now cleared for diagnostic viewing on desktop devices.
The approved advanced clinical applications on the browser-agnostic XERO Viewer now include Maximum Intensity Projection (MIP), MultiPlanar Reconstruction (MPR), mammography, orthopedics, nuclear medicine, and 3D visualization. In addition, iPad mobile diagnostic review and analysis now includes reports and ECG images.
The viewer can display images from either the Agfa HealthCare Enterprise Imaging IT platform, third-party Vendor Neutral Archives (VNA), or Picture Archiving and Communication Systems (PACS) in a single screen.
President of Imaging IT Solutions, Agfa HealthCare, James Jay, said, "We focus our continuous improvement efforts on meeting specific and real needs of healthcare providers; the features included in XERO Xtend fit that criterion. XERO, and the XERO Xtend feature set, help the healthcare enterprises to provide anywhere, anytime image access complete with powerful, useful image processing functions. The FDA 510(k) clearance for XERO Xtend supports our continued march forward."
Latest Imaging IT News
- Ambient AI Reporting Platform Streamlines Radiology Reporting
- Interactive AI Tool Supports Explainable Lung Nodule Assessment
- Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
Channels
Radiography
view channel
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read moreMRI
view channel
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read more
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read more
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read moreGeneral/Advanced Imaging
view channel
AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read moreNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







